Skip Navigation

European Heart Journal 2004 25(12):1085; doi:10.1016/j.ehj.2004.03.028
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cowie, M.R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cowie, M.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

B-type natriuretic peptide serum levels in acute heart failure: Reply

M.R. Cowie*

Clinical Cardiology, National Heart, Lung Institute, Dovehouse Street, London SW3 6LY, UK

* Tel.: +44-2073518856; fax: +44-2073518148
E-mail address: m.cowie@imperial.ac.uk

The first 10% of the full text of this article appears below.

Our review1 summarises the evidence of the clinical role of plasma BNP measurements in the management of patients in a variety of clinical settings and situations. As is clearly stated in the paper, and as all experienced physicians will know, BNP should not be . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?